Barclays lowered the firm’s price target on Zscaler to $135 from $143 and keeps an Equal Weight rating on the shares. The company’s billings grew 34% year-over-year in fiscal Q2, which digested two points of headwind from more ramp deals but also benefited from longer duration than expected, the analyst tells investors in a research note. The firm says this is the second quarter of deceleration, which reflects the different macro, but will also create more debate on competition.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ZS: